Ginkgo Bioworks (NYSE: DNA) insider Steve Coen plans Class A stock sale

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc. insider Steve Coen filed to sell Class A common stock under a planned transaction. The notice lists 752 Class A shares to be sold through Fidelity Brokerage Services on the NYSE and identifies the shares as originating from restricted stock vesting used as compensation. It also reports prior Class A stock sales over the last three months.

Key Figures

Planned Class A shares to be sold: 752 shares Associated amount for 752 shares: 5943.28 Prior sale shares on 04/17/2026: 324 shares +3 more

6 metrics

Planned Class A shares to be sold 752 shares Class A common stock listed for sale through Fidelity Brokerage Services on NYSE

Associated amount for 752 shares 5943.28 Amount reported alongside 752 Class A shares to be sold

Prior sale shares on 04/17/2026 324 shares Class A shares sold during the past 3 months

Amount for 04/17/2026 transaction 2576.36 Reported amount with 324 Class A shares transaction on 04/17/2026

Prior sale shares on 05/22/2026 307 shares Class A shares sold during the past 3 months

Amount for 05/22/2026 transaction 2558.63 Reported amount with 307 Class A shares transaction on 05/22/2026

Key Terms

Restricted Stock Vesting, compensation, Securities Sold During The Past 3 Months, Class A

4 terms

Restricted Stock Vesting financial

"Class A | 07/16/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

compensation financial

"752 | 07/16/2026 | Compensation"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

Class A financial

"Class A | Fidelity Brokerage Services LLC 900 Salem Street"

Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/17/2026 - 04:43 PM Accepted by SEC EDGAR 07/17/2026 - 04:42 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing by DNA’s Steve Coen disclose?

The filing discloses that Steve Coen intends to sell Class A common stock of Ginkgo Bioworks Holdings, Inc. It also details that the securities arise from restricted stock vesting granted as compensation and lists recent prior sales.

How many DNA Class A shares are planned for sale in this Form 144?

The notice lists 752 Class A shares of Ginkgo Bioworks Holdings, Inc. to be sold. These shares are associated with restricted stock vesting and are to be sold through Fidelity Brokerage Services on the NYSE.

What prior DNA stock sales by Steve Coen are reported in the last 3 months?

The filing reports two prior sales of DNA Class A stock: one on 04/17/2026 for 324 shares and another on 05/22/2026 for 307 shares. Each transaction includes associated transaction amounts for those dates.

What is the origin of the DNA shares Steve Coen plans to sell?

The shares are identified as originating from Restricted Stock Vesting provided by the issuer as compensation. This indicates they were initially granted to Steve Coen in a non-public, restricted form and later vested.

Through which broker will the planned DNA share sale be executed?

The filing states that the Class A shares are held at Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The shares are listed for trading on the NYSE exchange.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	752	5943.28	53361141	07/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	07/16/2026	Restricted Stock Vesting	Issuer			752	07/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steve Coen 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/17/2026	324	2576.36
Steve Coen 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/22/2026	307	2558.63

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)